Gabelli Healthcare & WellnessRx Trust (GRX) discloses GRX buys at $9.37 and $9.36

Q: Who filed the insider report for Gabelli Healthcare & WellnessRx Trust (GRX)?

The report was filed by Saba Capital Management, L.P. , signed by Zachary Gindes , and by Boaz Weinstein as reporting persons.

Q: Were GRX shares acquired or sold in this insider filing?

The transactions in this report were acquisitions of GRX common stock, with each line in Table I marked as A (acquired) and transaction code P for open-market or private purchases.

Q: What transaction code was used for the GRX insider trades?

The GRX transactions used code P , which indicates open-market or private purchases of the issuer's equity securities.

Q: Are there any derivative securities reported for GRX in this filing?

Table II for derivative securities is present but does not list any derivative transactions or holdings in the provided content.

Filing Impact

(Moderate)

Filing Sentiment

(Positive)

Form Type

Rhea-AI Filing Summary

Gabelli Healthcare & WellnessRx Trust reporting persons associated with Saba Capital Management, L.P. disclosed open-market purchases of the fund's common stock.

On December 16, 2025, they purchased 11,312 common shares at $9.37 per share, and on December 17, 2025 they purchased an additional 4,084 shares at $9.36. Following these transactions, they beneficially owned 2,118,201 shares of common stock held indirectly.

Insider Trade Summary

Net Buyer: 15,396 shares

Net Buy 2 txns

Insider Saba Capital Management, L.P.

Role 10% Owner

Bought 15,396 shs ($144K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	4,084	$9.36	$38K
Purchase	Common Stock	11,312	$9.37	$106K

Holdings After Transaction: Common Stock — 2,118,201 shares (Indirect, -)

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 12/18/2025 - 12:12 PM

FAQ

What insider transactions were reported for Gabelli Healthcare & WellnessRx Trust (GRX)?

The reporting persons disclosed two open-market purchases of common stock: 11,312 GRX shares at $9.37 on December 16, 2025, and 4,084 shares at $9.36 on December 17, 2025.

Who filed the insider report for Gabelli Healthcare & WellnessRx Trust (GRX)?

The report was filed by Saba Capital Management, L.P., signed by Zachary Gindes, and by Boaz Weinstein as reporting persons.

How many GRX shares are beneficially owned after the reported trades?

After the reported purchases, the reporting persons beneficially owned 2,118,201 GRX common shares, reported as indirect ownership.

Were GRX shares acquired or sold in this insider filing?

The transactions in this report were acquisitions of GRX common stock, with each line in Table I marked as A (acquired) and transaction code P for open-market or private purchases.

What transaction code was used for the GRX insider trades?

The GRX transactions used code P, which indicates open-market or private purchases of the issuer's equity securities.

Are there any derivative securities reported for GRX in this filing?

Table II for derivative securities is present but does not list any derivative transactions or holdings in the provided content.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Saba Capital Management, L.P.

(Last)

(First)

(Middle)

405 LEXINGTON AVENUE

58TH FLOOR

(Street)

NEW YORK

10174

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Gabelli Healthcare & WellnessRx Trust [ GRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	12/16/2025		P		11,312	A	$9.37	2,114,117	I	-
Common Stock	12/17/2025		P		4,084	A	$9.36	2,118,201	I	-

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

	Saba Capital Management, L.P. By: Zachary Gindes	12/18/2025
	Boaz Weinstein	12/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR